Analysis of the relationship between patients’ fear of falling and prescriber acceptance of pharmacists’ recommendations by Brown, Tenley
	 1	
Analysis	of	the	relationship	between	patients’	fear	of	falling	and	prescriber	acceptance	of	
pharmacists’	recommendations	
	
Tenley	Brown	is	a	PharmD	Candidate,	UNC	Eshelman	School	of	Pharmacy,	University	of	North	
Carolina	at	Chapel	Hill.	ORCID	0000-0002-6784-8255	
Jessica	Robinson,	PharmD	is	Community	Pharmacy	Practice	Research	Fellow,	Division	of	
Practice	Advancement	and	Clinical	Education,	UNC	Eshelman	School	of	Pharmacy,	University	of	
North	Carolina	at	Chapel	Hill.	ORCID	0000-0002-1276-7570	
Chelsea	Renfro,	PharmD	is	Assistant	Professor	and	Coordinator	of	Simulation-Based	Education,	
Department	of	Clinical	Pharmacy	and	Translational	Science,	University	of	Tennessee	Health	
Science	Center	College	of	Pharmacy,	Memphis,	TN.	ORCID	0000-0002-4090-8457	
Susan	J.	Blalock,	MPH,	PhD	is	Professor,	Division	of	Pharmaceutical	Outcomes	and	Policy,	UNC	
Eshelman	School	of	Pharmacy,	University	of	North	Carolina	at	Chapel	Hill.	ORCID	0000-0002-
8750-3385	
Stefanie	P.	Ferreri,	PharmD,	BCACP,	CDE,	FAPhA		is	Clinical	Professor,	Executive	Vice-Chair	and	
Co-Director,	PGY1	Independent	Pharmacy	Ownership	Residency	Program,	Division	of	Practice	
Advancement	and	Clinical	Education,	UNC	Eshelman	School	of	Pharmacy,	University	of	North	
Carolina	at	Chapel	Hill.	ORCID	0000-0002-1819-9631	Stefanie_ferreri@unc.edu	
	
	
	
	
	
	
	
	
	
	
	
	 2	
Abstract:	
Background:	Certain	medications	place	older	adults	at	higher	risk	for	experiencing	a	fall.	This	is	
a	modifiable	risk	factor	that	may	be	managed	by	community	pharmacists,	but	requires	
prescriber	acceptance	of	recommendations.	Previous	studies	indicate	that	prescriber	
acceptance	of	pharmacist	recommendations	may	be	impacted	by	patient-reported	concerns.	
Objective:	To	examine	the	relationship	between	patient-reported	fear	of	falling	and	prescriber	
acceptance	of	pharmacist	recommendations.	Methods:	A	prospective,	observational	study	
design	was	used.	Eligible	patients	were	age	65	and	older	and	received	care	at	one	of	31	
participating	pharmacies	in	North	Carolina.	Eligible	patients	were	screened	for	falls	risk	using	
three	evidence-based	questions;	patients	screening	positive	were	eligible	for	a	comprehensive	
medication	review.	Data	was	collected	via	a	prescriber	response	form.	The	primary	outcome	
was	the	prescriber	acceptance	of	pharmacist	recommendations.	Results:	Five	hundred	and	
sixty-two	recommendations	were	communicated	to	prescribers,	with	338	(60%)	for	patients	
who	worried	about	falling.	There	was	no	significant	difference	in	prescriber	acceptance	rate	
between	those	who	worried	about	falling	and	those	who	did	not	(36.1%	vs.	41.1%,	X2=0.23).	
Conclusion:	For	patients	who	indicated	they	had	a	fear	of	falling,	prescribers	were	not	more	
likely	to	consider	a	pharmacist’s	recommendations	regarding	medications	that	contribute	to	
falls	risk.		
	
Keywords:	community	pharmacy	services;	medication	therapy	management;	interdisciplinary	
communication;	aged;	fall	
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Introduction:	
Falls	in	older	adults	cause	a	significant	burden	to	both	patients	and	the	healthcare	
system.	Globally,	646,000	people	die	each	year	from	a	fatal	fall,	with	those	older	than	the	age	
of	65	at	the	greatest	risk	(World	Health	Organization.	Collaborating	Centre	for	Research	and	
Training	in	Mental	Health,	2018).	Following	a	nonfatal	fall,	patients	are	more	likely	to	report	
serious	and	non-serious	physical	injury,	as	well	as	decline	in	physical	and	social	activities	(Stel,	
Smit,	Pluijm,	&	Lips,	2004).	Furthermore,	one	estimate	placed	the	total	fall-related	medical	
costs	at	$50	billion	for	2015	in	the	United	States	alone,	making	fall	injuries	one	of	the	most	
expensive	medical	conditions	(Carroll,	Slattum,	&	Cox,	2005;	Florence	et	al.,	2018).	
While	a	wide	range	of	factors	may	contribute	to	an	individual’s	risk	of	falling,	evidence	
suggests	that	medication	use	may	play	a	significant	role.	A	meta-analysis	by	Woolcott	et	al.	
(2009)	found	a	significant	relationship	between	risk	of	falls	and	the	use	of	antidepressants,	
benzodiazepines,	sedatives/hypnotics,	antipsychotics,	and	other	medication	classes.	
Accordingly,	many	of	these	medications	are	included	in	the	American	Geriatrics	Society’s	Beers’	
Criteria	for	Potentially	Inappropriate	Medication	Use	in	Older	Adults	(Samuel,	2015).	These	
medications	are	often	referred	to	in	the	literature	as	“high-risk	medications”	due	to	their	
increased	risk	of	adverse	events,	including	falls,	in	older	adults.	One	study	shows	that	
medication	management	services	can	decrease	the	risk	of	falls	in	older	adults	by	39%	(Pit	et	al.,	
2007).	
Given	their	frequent	contact	with	patients	and	training	in	medication	management,	
community	pharmacists	can	play	an	important	role	in	reducing	high-risk	medication	use	and	
falls	risk	through	medication	management	services	(MMS)	(Casteel,	Blalock,	Ferreri,	Roth,	&	
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Demby,	2011).	A	key	component	of	MMS	in	the	community	pharmacy	setting	is	the	pharmacist-
led	medication	review,	which	is	defined	by	The	Joint	Commission	of	Pharmacy	Practitioners	as	
“a	spectrum	of	patient-centered,	pharmacist-provided,	collaborative	services	that	focus	on	
medication	appropriateness,	effectiveness,	safety,	and	adherence	with	the	goal	of	improving	
health	outcomes”	(Joint	Commission	of	Pharmacy	Practitioners,	2018).	MMS	performed	by	
pharmacists	has	been	demonstrated	to	be	both	economically	and	clinically	beneficial	for	
several	disease	states,	including	falls	prevention	(Doucette	et	al.,	2017;	Morrison	&	MacRae,	
2015).	Despite	evidence	of	improved	outcomes,	the	overall	rates	at	which	prescribers	
implement	pharmacists’	recommendations	following	medication	review	vary	widely	between	
studies	(Casteel	et	al.,	2011;	Doucette,	McDonough,	Klepser,	&	McCarthy,	2005;	Kwint,	
Bermingham,	Faber,	Gussekloo,	&	Bouvy,	2013;	Michaels,	Jenkins,	Pruss,	Heidrick,	&	Ferreri,	
2010;	Morrison	&	MacRae,	2015;	Roth	et	al.,	2013).	Reasons	reported	for	not	implementing	a	
pharmacist’s	recommendation	include	lack	of	willingness	of	the	patient,	lack	of	program	
engagement	by	the	primary	care	physician,	and	information	about	the	patients’	medical	
histories	that	was	unknown	to	the	pharmacist	(Morrison	&	MacRae,	2015;	Rose	et	al.,	2016).	
These	results	suggest	a	need	for	more	in-depth	analysis	of	factors	that	affect	prescriber	
implementation	rates.	
Another	factor	that	may	contribute	to	an	individual’s	risk	of	falling	is	having	a	fear	of	
falling,	with	several	studies	finding	that	patients	who	fear	falling	are	at	an	increased	risk	of	
falling	than	those	who	do	not	(Allali,	Ayers,	Holtzer,	&	Verghese,	2017;	Bruce,	Hunter,	Peters,	
Davis,	&	Davis,	2015;	Enderlin	et	al.,	2015;	Landers,	Oscar,	Sasaoka,	&	Vaughn,	2016).	The	
Centers	for	Disease	Control	(CDC)	has	developed	a	toolkit	that	addresses	risk	factors	such	as	
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fear	of	falling	and	high-risk	medication	use.	The	Stopping	Elderly	Accidents,	Deaths,	and	Injuries	
(STEADI)	toolkit	is	a	comprehensive	resource	guide	for	healthcare	professionals	to	assess	and	
address	falls	risk	in	their	patients	aged	65	and	older	(Stevens	&	Phelan,	2013).	This	toolkit	
provides	resources	and	tools	that	can	be	applied	across	a	wide	variety	of	practice	settings,	
including	community	pharmacies.		
While	several	studies	have	demonstrated	that	communication	strategies	and	
relationships	between	pharmacists	and	prescribers	may	influence	implementation	rates	(Kwint	
et	al.,	2013),	literature	regarding	clinical	factors	that	contribute	to	the	implementation	of	
pharmacists’	recommendations	by	prescribers	is	lacking.	One	study	by	Hanus	et	al.	(2016)	
analyzed	pharmacists’	interventions	using	the	anticholinergic	risk	scale	(ARS),	but	found	that	
neither	baseline	ARS	score	nor	baseline	number	of	medications	were	predictors	of	
implementation	rate.	This	suggests	that	even	robust	clinical	surrogates	may	not	influence	
prescribers’	willingness	to	alter	medication	therapy.	Boesen	et	al.	(2011)	analyzed	prescribers’	
implementation	of	pharmacist	recommendations	by	type	of	medication	therapy	problem	(MTP)	
(i.e.	guideline	adherence,	safety,	cost-saving)	and	found	that	prescribers	were	more	willing	to	
accept	recommendations	regarding	cost-savings	as	opposed	to	guideline	adherence	or	safety.	
Since	patients	report	being	less	likely	to	take	higher-cost	medications	(Dolovich	et	al.,	2008),	
this	result	suggests	that	prescribers	may	be	more	likely	to	address	MTPs	that	reflect	patient	
concerns.	As	stated	previously,	patients	who	fear	falling	are	at	a	higher	risk	for	falling.	This	fear	
also	has	a	negative	impact	on	their	quality	of	life	(Patil,	Uusi-Rasi,	Kannus,	Karinkanta,	&	
Sievänen,	2014).	Therefore,	we	hypothesized	that	fear	of	falling	may	be	a	patient	concern	that	
increases	prescriber	acceptance	of	pharmacist	recommendations	intended	to	mitigate	this	risk.	
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Methods	
	
Patient	Population	and	Study	Design	
Participants	in	this	study	were	a	subset	of	patients	from	a	randomized-controlled	trial	
currently	being	conducted	by	investigators	at	the	University	of	North	Carolina	Eshelman	School	
of	Pharmacy	with	funding	from	the	Centers	for	Disease	Control	and	Prevention	[Centers	for	
Disease	Control	and	Prevention,	Cooperative	Agreement	Number,	5	U01	CE002769-01].		A	total	
of	sixty-five	pharmacies,	all	located	in	North	Carolina,	participated	in	the	parent	study.		Thirty-
one	of	these	pharmacies	were	assigned	to	the	intervention	group.	Participants	included	in	this	
paper	were	limited	to	those	served	by	one	of	the	thirty-one	intervention-group	pharmacies.			
	 Patients	were	included	in	the	parent	study	if	within	the	three	months	prior	to	the	study,	
they:	(1)	were	age	≥	65	years,	(2)	filled	≥	80%	of	their	prescriptions	at	a	participating	pharmacy,	
and	(3)	took	≥	4	chronic	medications	of	any	kind	or	≥	1	high-risk	medications.	Medication	use	
was	determined	using	information	from	prescription	claims	and	dispensing	records.	For	the	
purpose	of	this	study,	high-risk	medications	included	antidepressants,	benzodiazepines,	opioid	
analgesics,	antipsychotics,	sedative	hypnotics,	anticonvulsants,	skeletal	muscle	relaxants,	
antihypertensives,	and	strongly	anticholinergic	medications.		
	 A	list	of	patients	who	met	the	eligibility	criteria	described	above	was	provided	to	each	
participating	pharmacy.	Pharmacy	staff	screened	eligible	patients	for	falls	risk	by	asking	the	
following	three	questions	from	the	STEADI	toolkit:	“Have	you	fallen	in	the	past	year?”,	“Do	you	
feel	unsteady	when	standing	or	walking?”,	and	“Do	you	worry	about	falling?”	If	a	patient	
responded	“yes,”	to	at	least	one	these	questions,	they	were	eligible	to	receive	a	comprehensive	
medication	review	(CMR).		
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During	the	CMR,	pharmacists	evaluated	the	patient’s	medication	regimen	for	high-risk	
medications	and	used	evidence-based	algorithms	developed	by	the	study	team	to	recommend	
medication	changes	aimed	at	reducing	the	patient’s	risk	of	falling.	Pharmacists	then	used	a	
prescriber	communication	form	(Appendix	A)	to	inform	the	patient’s	prescriber(s)	of	any	MTPs	
identified	and	corresponding	recommendations.	The	prescriber	communication	form	also	
provided	space	to	document	patient	responses	to	the	three	STEADI	screening	questions.		
	 Upon	receiving	a	recommendation	from	a	pharmacist,	prescribers	were	asked	complete	
a	prescriber	response	form	(Appendix	B)	that	included	the	following	two	statements:	(1)		“I	
plan	to	discuss	medication	information	with	the	patient	at	their	next	visit”	and	(2)	“I	plan	to	
make	changes	to	this	patient’s	medication	regimen	based	on	this	information.”	For	each	
statement,	prescribers	were	requested	to	select	either	“yes,”	“no,”	or	“unsure”.		Pharmacists	
were	required	to	reach	out	to	prescribers	a	minimum	of	two	times	to	demonstrate	a	good	faith	
effort	to	obtain	a	completed	response	form	back	from	each	prescriber.	
	 Participants	included	in	this	paper	were	limited	to	those	who	screened	positive	for	falls	
risk	(i.e.,	answered	“yes”	to	at	least	one	of	the	three	STEADI	screening	questions),	received	a	
CMR,	and	had	at	least	one	specific	medication	regimen	change	recommendation	recorded	on	
the	prescriber	communication	form.	Regimen	changes	could	include	a	change	in	dose,	agent,	
administration	or	other	change	as	determined	by	investigators.	
	
Primary	outcome	variable	
The	primary	outcome	was	prescriber	acceptance	of	medication	recommendations.	A	
recommendation	was	coded	as	accepted	if	the	prescriber	checked	“yes”	to	either	“I	will	discuss	
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medication	information	with	the	patient	at	their	next	visit”	or	“I	will	make	changes	to	the	
patient’s	medication	regimen	based	on	this	information.”	Recommendations	for	which	follow-
up	from	the	prescriber	was	not	obtained	were	considered	not	accepted.	
	
Predictor	variable	
The	primary	predictor	variable	was	participant	response	to	the	question	“Do	you	worry	
about	falling?”	(Y/N),	administered	during	the	screening	process.	
	
Data	analysis	
Data	were	analyzed	using	SAS	University	Edition	software	(SAS	Institute	Inc,	Cary,	North	
Carolina).		A	chi-square	test	was	performed	to	determine	if	the	proportion	of	pharmacist	
recommendations	accepted	by	prescribers	differed	between	patients	who	reported	being	
worried	about	falling	compared	to	those	who	reported	that	they	were	not	worried	about	
falling.		This	relationship	was	also	examined	using	logistic	regression	to	control	for	age,	gender,	
and	pharmacy.	Statistical	significance	was	evaluated	with	Type	I	error	set	at	p	<	0.05.	
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Results	
Participants	were	primarily	female	(73%)	with	a	mean	age	of	75.7	±	7.9	years.	This	was	
similar	between	cohorts.	Medication	recommendations	were	communicated	to	prescribers	on	
562	occasions	for	550	unique	patients.	Individual	patients	may	have	been	included	more	than	
once	if	medication	recommendations	were	sent	to	multiple	prescribers.	Qualifying	medication	
recommendations	were	collected	from	28	of	the	31	participating	pharmacies.	One	pharmacy	
did	not	complete	any	CMRs,	and	two	others	did	not	make	any	medication	recommendations	as	
part	of	their	completed	CMRs	and	were	therefore	not	included	in	the	final	analysis.	As	shown	in	
Figure	1,	338	(60%)	recommendations	were	for	patients	who	indicated	that	they	worried	about	
falling.			
	
Prescriber	Acceptance	
Overall,	214	(38.1%)	recommendations	were	accepted	by	prescribers.	The	difference	in	
prescriber	acceptance	rate	between	patients	who	reported	worrying	about	falling	and	those	
who	did	not	was	not	statistically	significant	(36.1%	vs.	41.1%,	respectively,	X2=0.23).		This	
difference	remained	nonsignificant	after	controlling	for	age,	gender,	and	pharmacy		(p=0.83).		
	
Prescriber	Acceptance	by	Pharmacy	
The	median	acceptance	rate	across	the	28	pharmacies	that	made	qualifying	
recommendations	was	33%,	with	acceptance	rates	for	individual	pharmacies	ranging	from	0%	
to	100%.	Of	the	28	included	pharmacies,	22	(79%)	had	acceptance	rates	of	less	than	or	equal	to	
50%.	An	exploratory	logistic	regression	analysis	was	performed	to	analyze	the	effect	of	the	
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individual	pharmacy	on	prescriber	acceptance	rate,	controlling	for	patients’	worry	about	falling,	
age,	and	gender.	This	analysis	showed	a	statistically	significant	difference	in	acceptance	rates	
(p=0.047)	across	the	individual	pharmacies.	Figure	2	shows	the	distribution	of	acceptance	rates	
by	pharmacy.		
	
Discussion:	
	
Community	pharmacists	have	the	ability	to	identify	patients	at	an	increased	risk	for	falls	
and	leverage	their	expertise	in	medication	therapy	to	reduce	this	risk.	This	study	and	others	
show,	however,	that	acceptance	of	falls-related	medication	recommendations	by	prescribers	is	
highly	variable.	
The	results	of	this	study	suggest	that	knowledge	related	to	patient	concerns	about	
falling	does	not	influence	prescribers’	decision	to	accept	a	falls-related	medication	
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recommendation	from	a	community	pharmacist.	Consequently,	more	research	examining	
clinical	factors	that	may	be	leveraged	to	encourage	collaboration	between	pharmacists	and	
their	patients’	prescribers	is	needed.	That	being	said,	it	is	widely	acknowledged	that	a	
productive	relationship	between	pharmacists	and	prescribers	is	multifactorial	and	the	fact	that	
this	study	demonstrated	substantial	variability	in	acceptance	rates	between	individual	
pharmacies	supports	this	concept.		
This	study	was	novel	in	its	attempt	to	probe	the	impact	of	the	patient-concerning	factor	
of	fear	of	falling	in	the	CMR	process.	Importantly,	it	is	unreasonable	to	expect	most	patients	to	
understand	the	psychologic	and	physiologic	relationships	between	their	worries	about	falling,	
their	medication	regimen,	and	the	risk	of	falling.	Given	the	results	of	the	study	and	the	limited	
impact	that	fear	of	falling	seems	to	have	on	prescriber	acceptance	of	pharmacist	
recommendations	related	to	high-risk	medications,	it	may	be	reasonable	to	expect	that	a	
patient	who	does	not	understand	the	relationship	between	their	medications	and	fall	risk	may	
not	feel	empowered	to	make	changes	to	their	medication	regimen.	In	this	study,	data	were	not	
collected	regarding	whether	recommendations	were	also	communicated	to	the	patient,	nor	if	
the	patient	was	accepting	of	the	recommendation.	Although	patients	may	not	initially	make	the	
connection	between	a	medication	they	are	taking	and	their	risk	of	falls,	explaining	this	
information	to	them	during	a	CMR	and	documenting	a	willingness	to	make	medication	changes	
may	be	useful	information	to	provide	to	their	prescriber.	A	pilot	study	by	Mott	et	al.	
implemented	a	similar	falls	prevention	program	to	the	one	described	here,	but	with	a	key	
difference:	changes	in	over-the-counter	(OTC)	product	use	were	included	in	their	analysis.(Mott	
et	al.,	2016)	This	study	showed	a	relatively	high	overall	recommendation	acceptance	rate	of	
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75%,	speculated	to	be	largely	due	to	the	inclusion	of	OTC	products,	which	importantly,	can	be	
changed	by	the	patient	without	prescriber	consent	(Mott	et	al.,	2016).	This	result	suggests	that	
patients	are	willing	to	make	informed	decisions	about	their	medication	therapy	when	
empowered,	and	that	perhaps	by	more	directly	involving	patients	in	the	decision-making	
process,	it	may	result	in	improved	outcomes.	Despite	significant	advancements	in	the	role	of	
pharmacists	as	members	of	the	healthcare	team,	more	research	is	required	into	the	
pharmacist’s	role	in	patient-centered	care,	particularly	as	it	relates	to	patient	engagement.	
	
Limitations:	
There	are	several	limitations	to	this	study.	First,	the	study	was	conducted	in	independent	
community	pharmacies	in	North	Carolina	that	provide	established	clinical	services,	which	may	
limit	generalizability	to	other	geographic	areas	and	pharmacies	with	less	well-established	
clinical	services.	In	addition,	the	definition	of	prescriber	acceptance	for	the	purposes	of	this	
study	was	indirect,	as	the	prescribers’	indication	of	plans	to	discuss	or	change	medications	does	
not	necessarily	mean	that	the	changes	were	implemented.	Ideally,	a	study	would	use	claims	
data	to	determine	if	the	recommended	medication	changes	were	actually	implemented	and	
maintained	over	a	period	of	time.	Furthermore,	as	previously	mentioned,	there	was	a	broad	
distribution	of	acceptance	rates	between	participating	pharmacies	suggesting	that	additional	
variables	might	play	a	more	significant	role	in	prescriber	acceptance.	Further	research	is	
warranted	to	determine	those	aspects	of	individual	pharmacies	and	pharmacists	that	may	
influence	prescriber	acceptance	of	community	pharmacists’	recommendations.	
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Conclusion:	
This	study	found	no	difference	in	the	rate	of	prescriber	acceptance	of	pharmacists’	
recommendations	between	those	patients	who	worry	about	falling	and	those	who	do	not.	
Pharmacists	have	the	knowledge	and	tools	to	address	potentially	inappropriate	medication	use	
in	their	older	adult	patients	to	reduce	their	fall	risk.	However,	traditional	barriers	to	
implementation	and	success	of	clinical	services	in	the	community	pharmacy	setting	remain.	This	
study	indicates	the	importance	of	continued	research	on	strategies	for	effective	collaboration	
between	patients,	community	pharmacists,	and	prescribers.		
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